Trial intelligence / Profile preview

Analgesic efficacy of escitalopram vs amitriptyline in painful peripheral neuropathy associated with HIV infection

2007-000516-93Phase 4Active

Sponsor
César Margarit Ferri
Start
Feb 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of escitalopram and amitriptyline in Peripheral neuropathic pain and human immunodeficiency virus infection (HIV) (2 arms), sponsored by César Margarit Ferri. Primary endpoint: Primary analgesic efficacy at 6 months. Started Feb 2008; status: active.

02

Drugs

escitalopramamitriptyline
03

Conditions

Peripheral neuropathic painhuman immunodeficiency virus infection (HIV)

Beyond the preview

Go deeper on 2007-000516-93.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-000516-93.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call